Format

Send to

Choose Destination
F1000Prime Rep. 2014 Jul 8;6:50. doi: 10.12703/P6-50. eCollection 2014.

Recent advances in the understanding and management of rosacea.

Author information

1
Department of Dermatology and Allergology Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067 Dresden Germany.

Abstract

Rosacea is a chronic relapsing inflammatory facial dermatosis. There are several known triggers but the pathogenesis remains unknown. Recent achievements in understanding this disease point to the importance of skin-environmental interactions. This includes physical and chemical factors, but also microbial factors. The impairment of the skin barrier function and the activation of the innate immune defences are major and connected pathways contributing to an ongoing inflammatory response in the affected skin. This becomes modulated by endogenous factors like neurovascular, drugs, and psychological factors. These factors offer new therapeutic targets for rosacea treatment. There is a broader range of anti-inflammatory compounds available with a favourable safety record. Only recently have persistent erythema and flushing been addressed by new drug formulations.

Supplemental Content

Full text links

Icon for Faculty of 1000 Icon for PubMed Central
Loading ...
Support Center